Literature DB >> 9486394

Monocytes modulate enhancement of HIV-1 replication by Mycobacterium tuberculosis.

C J De Haas1, N M de Vos, M R Visser, H Snippe, J Verhoef.   

Abstract

To investigate the effects of Mycobacterium tuberculosis on HIV-1 replication, peripheral blood mononuclear cells (PBMC) of bacille Calmette-Guerin (BCG)-vaccinated donors and non-BCG-vaccinated donors were infected in vitro with a lymphotropic isolate of HIV-1 and cultured in the presence of purified protein derivative (PPD). Addition of PPD resulted in enhanced HIV-1 replication and lymphoproliferation in BCG-vaccinated donor PBMC, while PPD had no such effects in control PBMC. HIV-1 replication increased even more when monocytes were removed from PBMC, while lymphoproliferation was decreased. High percentages of monocytes were associated with a decreased HIV-1 replication and proliferation that could not be reversed by addition of antibodies against the cytokines IL-1, transforming growth factor-beta (TGF-beta) or indomethacin. PPD stimulates PBMC to release IL-10, a cytokine known to down-regulate proliferation and HIV-1 replication. PPD-induced effects on proliferation as well as HIV-1 replication could be partially blocked by adding a monoclonal antibody against MHC class II molecules, suggesting that part of the mechanism of PPD-induced enhancement is T memory cell activation.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9486394      PMCID: PMC1904906          DOI: 10.1046/j.1365-2249.1998.00494.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  44 in total

1.  Mannoproteins of Cryptococcus neoformans induce proliferative response in human peripheral blood mononuclear cells (PBMC) and enhance HIV-1 replication.

Authors:  J M Orendi; A F Verheul; N M De Vos; M R Visser; H Snippe; R Cherniak; V V Vaishnav; G T Rijkers; J Verhoef
Journal:  Clin Exp Immunol       Date:  1997-02       Impact factor: 4.330

2.  Suppressor adherent cells in human tuberculosis.

Authors:  J J Ellner
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

3.  Tumor necrosis factor alpha induces expression of human immunodeficiency virus in a chronically infected T-cell clone.

Authors:  T M Folks; K A Clouse; J Justement; A Rabson; E Duh; J H Kehrl; A S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

4.  Augmentation of human immunodeficiency virus type 1 gene expression by tumor necrosis factor alpha.

Authors:  T Okamoto; T Matsuyama; S Mori; Y Hamamoto; N Kobayashi; N Yamamoto; S F Josephs; F Wong-Staal; K Shimotohno
Journal:  AIDS Res Hum Retroviruses       Date:  1989-04       Impact factor: 2.205

5.  Direct stimulation of monocyte release of interleukin 1 by mycobacterial protein antigens.

Authors:  R S Wallis; H Fujiwara; J J Ellner
Journal:  J Immunol       Date:  1986-01       Impact factor: 5.422

6.  Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens.

Authors:  S E Valone; E A Rich; R S Wallis; J J Ellner
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

7.  Association of altered dynamics of monocyte surface expression of human leukocyte antigen DR with immunosuppression in tuberculosis.

Authors:  D J Tweardy; B Z Schacter; J J Ellner
Journal:  J Infect Dis       Date:  1984-01       Impact factor: 5.226

8.  Increased interleukin-1 production and monocyte suppressor cell activity associated with human tuberculosis.

Authors:  H Fujiwara; M E Kleinhenz; R S Wallis; J J Ellner
Journal:  Am Rev Respir Dis       Date:  1986-01

9.  Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B.

Authors:  L Osborn; S Kunkel; G J Nabel
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

10.  The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection.

Authors:  V Kindler; A P Sappino; G E Grau; P F Piguet; P Vassalli
Journal:  Cell       Date:  1989-03-10       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.